Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2023-02-14 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today, ie. 14th February, 2023 has considered ....
Regulatory Filings
2023-02-14 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document text is extremely short (507 characters) and contains only a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no indication of any report, announcement, or financial data. Given the lack of content and the presence of a digital signature, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2023-02-03 English
WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve Notice is hereby given pursuant to ....
Regulatory Filings
2023-02-03 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2023-01-03 English
Pursuant to Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith Certificate dated 2nd January, 2022 ....
Regulatory Filings
2023-01-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (495 characters) and consists solely of a digital signature block with no substantive content related to financial performance, management changes, voting results, or any other reportable corporate event. There is no indication of a report, announcement, or any specific filing type. Given the lack of content and the nature of the text, it does not fit any specific filing category and defaults to the fallback category for miscellaneous filings.
2022-12-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.